Pollak M - Search Results

1

Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL. Horne HN, et al. Among authors: pollak m. Breast Cancer Res. 2016 Feb 18;18(1):24. doi: 10.1186/s13058-016-0678-4. Breast Cancer Res. 2016. PMID: 26893016 Free PMC article.

2

Tamoxifen reduces serum insulin-like growth factor I (IGF-I).

Pollak MN, Huynh HT, Lefebvre SP. Pollak MN, et al. Breast Cancer Res Treat. 1992;22(1):91-100. doi: 10.1007/BF01833337. Breast Cancer Res Treat. 1992. PMID: 1421427 Review.

3

Presence of somatomedin receptors on primary human breast and colon carcinomas.

Pollak MN, Perdue JF, Margolese RG, Baer K, Richard M. Pollak MN, et al. Cancer Lett. 1987 Dec;38(1-2):223-30. doi: 10.1016/0304-3835(87)90218-7. Cancer Lett. 1987. PMID: 2961436

4

The human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer.

Tonin P, Ehrenborg E, Lenoir G, Feunteun J, Lynch H, Morgan K, Zazzi H, Vivier A, Pollak M, Huynh H, et al. Tonin P, et al. Among authors: pollak m. Genomics. 1993 Nov;18(2):414-7. doi: 10.1006/geno.1993.1487. Genomics. 1993. PMID: 7507078

5

Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation.

Pratt SE, Pollak MN. Pratt SE, et al. Among authors: pollak mn. Biochem Biophys Res Commun. 1994 Jan 14;198(1):292-7. doi: 10.1006/bbrc.1994.1041. Biochem Biophys Res Commun. 1994. PMID: 7507320

6

Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.

Huynh H, Pollak M. Huynh H, et al. Among authors: pollak m. Cancer Res. 1994 Jun 15;54(12):3115-9. Cancer Res. 1994. PMID: 7515764

7

Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.

Pratt SE, Pollak MN. Pratt SE, et al. Among authors: pollak mn. Cancer Res. 1993 Nov 1;53(21):5193-8. Cancer Res. 1993. PMID: 7693333

8

Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.

Huynh HT, Pollak M. Huynh HT, et al. Among authors: pollak m. Cancer Res. 1993 Dec 1;53(23):5585-8. Cancer Res. 1993. PMID: 8242606

9

Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy.

Friedl A, Jordan VC, Pollak M. Friedl A, et al. Among authors: pollak m. Eur J Cancer. 1993;29A(10):1368-72. doi: 10.1016/0959-8049(93)90003-x. Eur J Cancer. 1993. PMID: 8398260

10

In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen.

Huynh HT, Tetenes E, Wallace L, Pollak M. Huynh HT, et al. Among authors: pollak m. Cancer Res. 1993 Apr 15;53(8):1727-30. Cancer Res. 1993. PMID: 8467486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

850 results

Search Page